An allelotype of papillary thyroid cancer

被引:0
|
作者
Califano, JA
Johns, MM
Westra, WH
Lango, MN
Eisele, D
Saji, M
Zeiger, MA
Udelsman, R
Koch, WM
Sidransky, D
机构
[1] JOHNS HOPKINS UNIV HOSP,DEPT OTOLARYNGOL HEAD & NECK SURG,HEAD & NECK CANC RES DIV,BALTIMORE,MD 21205
[2] JOHNS HOPKINS UNIV HOSP,DEPT PATHOL,BALTIMORE,MD 21205
[3] JOHNS HOPKINS UNIV HOSP,DEPT GEN SURG,BALTIMORE,MD 21205
[4] JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD
[5] NYU,SCH MED,NEW YORK,NY
关键词
D O I
10.1002/(SICI)1097-0215(19961220)69:6<442::AID-IJC3>3.0.CO;2-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although papillary carcinoma accounts for approximately 70% of all thyroid cancers, preliminary studies of allelic loss have thus far not identified any areas of chomosomal deletion. We evaluated 30 papillary thyroid carcinomas for chromosomal loss/allelic imbalance by testing at least 2 microsatellite markers from every autosomal arm. Fifteen of the 30 tumors tested exhibited loss of heterozygosity/allelic imbalance (LOH/AI) at one or more loci. Chromosomal arms with frequent LOH/AI included 4q, 5p, 7p and 11p. An average of 1.1 chromosomal arms displayed LOH/AI in each individual tumor. Therefore, 4q, 5p, 7p and, to a lesser extent, 11p display significant LOH/AI in papillary thyroid cancer, which indicates the presence of putative tumor-suppressor gene loci at these chromosomal arms. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:442 / 444
页数:3
相关论文
共 50 条
  • [41] Serum biomarkers of papillary thyroid cancer
    Fawaz M Makki
    S Mark Taylor
    Ali Shahnavaz
    Andrew Leslie
    Jeffrey Gallant
    Susan Douglas
    Evelyn Teh
    Jonathan Trites
    Martin Bullock
    Karen Inglis
    Devanand M Pinto
    Robert D Hart
    Journal of Otolaryngology - Head & Neck Surgery, 42
  • [42] MicroRNA Profiling in Papillary Thyroid Cancer
    Armos, Richard
    Bojtor, Bence
    Papp, Marton
    Illyes, Ildiko
    Lengyel, Balazs
    Kiss, Andras
    Szili, Balazs
    Tobias, Balint
    Balla, Bernadett
    Piko, Henriett
    Illes, Anett
    Putz, Zsuzsanna
    Toth, Erika
    Takacs, Istvan
    Kosa, Janos P.
    Lakatos, Peter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [43] Serum biomarkers of papillary thyroid cancer
    Makki, Fawaz M.
    Taylor, S. Mark
    Shahnavaz, Ali
    Leslie, Andrew
    Gallant, Jeffrey
    Douglas, Susan
    Teh, Evelyn
    Trites, Jonathan
    Bullock, Martin
    Inglis, Karen
    Pinto, Devanand M.
    Hart, Robert D.
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2013, 42
  • [44] Sex Differences in Papillary Thyroid Cancer
    Remer, Lindsay F.
    Lee, Christina I.
    Picado, Omar
    Lew, John I.
    JOURNAL OF SURGICAL RESEARCH, 2022, 271 : 163 - 170
  • [45] Treatment resistant papillary thyroid cancer
    Lin, Jaime
    Hng, Tien-Ming
    CLINICAL ENDOCRINOLOGY, 2016, 84 : 39 - 40
  • [46] Be(a)ware of Leukocytosis in Papillary Thyroid Cancer
    Laskou, Styliani
    Sapalidis, Konstantinos
    Topalidis, Christos
    Koletsa, Triantafyllia
    Kesisoglou, Isaak
    CASE REPORTS IN ENDOCRINOLOGY, 2022, 2022
  • [47] Diabetes and infarcted papillary thyroid cancer
    Haddad, FH
    Malkawi, OM
    Omari, AA
    Izzat, AS
    Khassrof, HM
    Faiad, LM
    Okla, AL
    Jamil, AN
    SAUDI MEDICAL JOURNAL, 2002, 23 (04) : 467 - 470
  • [48] Thyroid remnant ablation in papillary cancer
    Kuna, S. Kusacic
    Samardzic, T.
    Ciglar, M.
    Bracic, I.
    Despot, M.
    Herceg, G. Horvatic
    Mutvar, A.
    Dodig, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S354 - S354
  • [49] Papillary thyroid cancer: Monitoring and therapy
    Tuttle, R. Michael
    Leboeuf, Rebecca
    Martorella, Andrew J.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2007, 36 (03) : 753 - +
  • [50] Aggressive variants of papillary thyroid cancer
    Roman, Sanziana
    Sosa, Julie A.
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (01) : 33 - 38